NHS Greater Glasgow & Clyde OMS TPS Replacement
Description: Greater Glasgow Health Board (more commonly known as NHS Greater Glasgow and Clyde) operates the Beatson West of Scotland Cancer Centre (being the Gartnavel General Hospital and the Lanarkshire Beatson) and has a requirement to replace its treatment Oncology Management System (OMS) and Treatment Planning System (TPS) under the Scottish Government's Radiotherapy Capital Equipment Replacement Programme (CERP). This NHS Requirement includes the provision for the purchase of the following Products: Lot 1: Oncology Management System (OMS) and Record and Verify System (R&V) Lot 2: Treatment Planning System (TPS) Contractors may tender for any single, or both, lots. Separate tenders should be submitted for each lot. Contractors may submit more than 1 tender for any given lot. A single tender for more than 1 lot combined will not be (read more...)
Summary: NHS Greater Glasgow and Clyde is currently in the tender stage for the replacement of its Oncology Management System (OMS) and Treatment Planning System (TPS) at the Beatson West of Scotland Cancer Centre in Glasgow. This procurement is part of the Scottish Government’s Radiotherapy Capital Equipment Replacement Programme and falls under the healthcare industry category related to radiotherapy and physical therapy devices. The contract, valued at GBP 2.6 million, is divided into two lots, each with a contract duration of two years. Businesses interested in participating must submit their tenders electronically by 2nd June 2026, with the award decision and bid opening also taking place on the same date. The process is conducted through an open procurement method, allowing any qualified supplier to bid, and is covered by the GPA trade agreement.